Drug Profile
IS 002
Alternative Names: IS-002Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator ImmuSmol
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Neurological-disorders in France (Parenteral)
- 21 Jul 2016 Early research in Neurological disorders in France (Parenteral)